An observational study in Brain Death, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Status unknown at 1 site in China. Open to participants aged 12 Years to 72 Years. Per ClinicalTrials.gov, last updated 2021-06-04.
Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Observational
At present, different countries have different standards for the diagnosis of brain death, but according to the classic brain death confirmation test, it needs to be combined with transcranial Doppler, EEG, evoked potential and apnea test in clinical practice. Some patients cannot undergo a complete clinical examination and apnea test due to certain factors, and the determination of brain death is limited. The American Academy of Neurology (AAN) guidelines regard cerebral angiography as an acceptable auxiliary examination and is widely regarded as the gold standard for cerebral blood flow evaluation. CT cerebrovascular angiography (CTA) is a noninvasive and widely used examination method that can identify missing or severely reduced cerebral blood flow. However, due to limited experience and lack of sufficient evidence to prove its reliability, it is not included in the AAN A recognized auxiliary examination; there are also a large number of domestic and foreign literature reports that CTA can be used as a new confirmation test for clinical judgment of brain death.
This study aims to explore the value of CTA in the judgment of patients with brain death.
74 studies on the registry are indexed under Brain Death; 10 are open to participants now.
This study's planned enrollment of 63 is below the median of 80 across 33 observational studies indexed under Brain Death.
Browse Brain Death studies →Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,047 studies on the registry; 502 are open to participants now.
Counted across the registry records on this site, refreshed daily.
CTA imaging data of 63 patients with clinically suspected brain death
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
CTA examination group for suspected brain death
Combination Product: Combination Product
Confirmed group for brain death
Other: NO CTA examination
Cases of brain death confirmed by the classic brain death confirmation test
NO CTA examination
CTA used as an auxiliary diagnosis to determine brain death
CTA used as an auxiliary diagnosis to determine brain death
Time frame: through study completion, an average of 3 years.
Plan to share: Undecided
No publications or documents are linked to this record.
Started Feb 2021 (actual). Primary completion is estimated for Feb 2022, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital, School of Medicine, Zhejiang University →